OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting galectin-3 in inflammatory and fibrotic diseases
Selena Bouffette, Iuliana Botez, Frédéric De Ceuninck
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 8, pp. 519-531
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
Beata Zaborska, Małgorzata Sikora-Frąc, Krzysztof Smarż, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13111-13111
Open Access | Times Cited: 44

End-Point Affinity Estimation of Galectin Ligands by Classical and Semiempirical Quantum Mechanical Potentials
Jan Choutka, Jakub Kaminský, Ercheng Wang, et al.
Journal of Chemical Information and Modeling (2025)
Open Access | Times Cited: 2

Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer
Fredrik R. Zetterberg, Kristoffer Peterson, Ulf J. Nilsson, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9374-9388
Closed Access | Times Cited: 10

Impact of smoking on Galectin-3 and GDF-15 among pregnant women
Ahmad Al-Rweis, Zainab Zakaraya, Laila Al-Omari, et al.
Tamjeed Journal of Healthcare Engineering and Science Technology (2024) Vol. 2, Iss. 1, pp. 1-12
Open Access | Times Cited: 5

Left ventricular hypertrophy in young hypertensives: the possible crosstalk of mTOR and angiotensin-II -a case-control study
Busayo Onafowoke Oguntola, Stephen Olawale Oguntola, Opeyemi Ezekiel Ojo, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access

Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials
Samuel Dinerman, Yan Shu
International Journal of Translational Medicine (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access

New perspectives on galectin in major depressive disorder treatment
Laura Cabral Peixoto, Michelle Melgarejo da Rosa
Biochemical Pharmacology (2025) Vol. 233, pp. 116786-116786
Closed Access

Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center
Milica Brajković, Sofija Nikolić, Višeslav Popadić, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 375-375
Open Access

Phaseolus coccineus Seed: A Valued Resource for Bioactive Compounds Targeting Health and Tumor Cells
Rita Russo, Antonio Colantuono, Sonia Di Gaetano, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2189-2189
Open Access

Essential roles of sensory nerve in maintenance of cornea-phenotype in mice
Yuka Okada, Takayoshi Sumioka, Hiroki Iwanishi, et al.
The Ocular Surface (2025)
Closed Access

BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators
Renju Pun, Aradhana Thapa, S. Takafuji, et al.
Journal of the American Heart Association (2025)
Open Access

Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial
Luca Monzo, Masatake Kobayashi, João Pedro Ferreira, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access

Systematic Review of Advanced Inflammatory Markers as Predictors of Cardiovascular Diseases
Thai Hau Koo, Xue Bin Leong, Mafauzy Mohamed
Research in Cardiovascular Medicine (2025) Vol. 14, Iss. 1, pp. 8-14
Open Access

Cigarette smoke-induced galectin-3 as a diagnostic biomarker and therapeutic target in lung tissue remodeling
Jiten R. Sharma, Anupama Dubey, Umesh C. S. Yadav
Life Sciences (2024) Vol. 339, pp. 122433-122433
Closed Access | Times Cited: 3

Toxicological evaluation of a pumpkin-derived pectin preparation: in vitro genotoxicity studies and a 13-week oral toxicity study in Sprague-Dawley rats
Anne F. Kleijn, Margien Mutter, James Akingbasote, et al.
Toxicology Research (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3

Validity of galactin-3 in acromegaly: comparison with traditional markers
Maryam Thaer Saadi, Noor Ulhuda G. Mohammed, Baydaa Ahmed Abed, et al.
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 4, pp. 1837-1841
Closed Access | Times Cited: 3

Understanding Galectin-3's Role in Diastolic Dysfunction: A Contemporary Perspective
Wen‐Rui Hao, Chun‐Han Cheng, Ju‐Chi Liu, et al.
(2024)
Open Access | Times Cited: 3

CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 328-362
Closed Access | Times Cited: 3

LGALS3 regulates endothelial-to-mesenchymal transition via PI3K/AKT signaling pathway in silica-induced pulmonary fibrosis
Demin Cheng, Wenxiu Lian, Xinying Jia, et al.
Toxicology (2024) Vol. 509, pp. 153962-153962
Closed Access | Times Cited: 3

Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis
Céline Ortega-Ferreira, Perrine Soret, Gautier Robin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9

Emerging role of galectin 3 in neuroinflammation and neurodegeneration
Brian M. Lozinski, Khanh Ta, Yifei Dong
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 2004-2009
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top